Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Clinical Studies

Comment on “Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients”

British Journal of Cancer volume 128, pages 711–712 (2023)Cite this article

Subjects

To the Editor,

We read with interest the editorial and review paper published in the British Journal of Cancer on September 29, 2022 discussing theshort-chain fatty acids (SCFA) in patients treated with pelvic radiotherapy [1, 2].

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Data availability

Not applicable.

References

  1. Eaton SE, Kaczmarek J, Mahmood D, McDiarmid AM, Norarfan AN, Scott EG, et al. Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients. Br J Cancer. 2022;127:2087–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vodnar DC, Calinoiu LF, Mitrea L. Editorial: exploiting the effect of dietary fibre on the gut microbiota in patients with pelvic radiotherapy. Br J Cancer. 2022;127:1575–6.

    Article  PubMed  Google Scholar 

  3. Murray J, Cruickshank C, Bird T, Bell P, Braun J, Chuter D, et al. PEARLS—a multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation. Clin Transl Radiat Oncol. 2022;37:130–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Reis Ferreira M, Khan A, Thomas K, Truelove L, McNair H, Gao A, et al. A phase I/II dose escalation study of the use of intensity modulated radiotherapy (IMRT) to treat the prostate and pelvic nodes in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2017; http://linkinghub.elsevier.com/retrieve/pii/S0360301617336556.

  5. Hauer-Jensen M, Denham JW, Andreyev HJN. Radiation enteropathy—pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11:470–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Queen J, Domingue JC, White JR, Stevens C, Udayasuryan B, Nguyen TTD, et al. Comparative analysis of colon cancer-derived fusobacterium nucleatum subspecies: inflammation and colon tumorigenesis in murine models. mBio. 2022;13:e0299121.

    Article  Google Scholar 

  7. Wedlake L, Shaw C, McNair H, Lalji A, Mohammed K, Klopper T, et al. Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy. Am J Clin Nutr. 2017;106:849–57.

    Article  CAS  PubMed  Google Scholar 

  8. Reis Ferreira M, Andreyev J, Mohammed K, Truelove L, Gowan SM, Li J, et al. Microbiota and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late radiation enteropathy. Clin Cancer Res. 2019;25:6487–500.

    Article  PubMed  Google Scholar 

  9. Ferreira MR, Sands CJ, Li JV, Andreyev JN, Chekmeneva E, Gulliford S, et al. Impact of pelvic radiation therapy for prostate cancer on global metabolic profiles and microbiota-driven gastrointestinal late side effects: a longitudinal observational study. Int J Radiat Oncol Biol Phys. 2021;111:1204–13.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Guo H, Chou WC, Lai Y, Liang K, Tam JW, Brickey WJ, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020;370:eaay9097.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Levy A, Stedman A, Deutsch E, Donnadieu F, Virgin HW, Sansonetti PJ, et al. Innate immune receptor NOD2 mediates LGR5+ intestinal stem cell protection against ROS cytotoxicity via mitophagy stimulation. Proc Natl Acad Sci USA. 2020;117:1994–2003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Guys and St Thomas NHS Foundation Trust, London, UK

    Miguel R. Ferreira

  2. King’s College London, London, UK

    Miguel R. Ferreira

  3. United Lincolnshire Hospitals NHS Trust, Lincoln, UK

    Jervoise N. Andreyev

  4. The Royal Marsden NHS Foundation Trust, London, UK

    Linda Wedlake & David P. Dearnaley

  5. The Institute of Cancer Research, London, UK

    David P. Dearnaley

Authors
  1. Miguel R. Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jervoise N. Andreyev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda Wedlake
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David P. Dearnaley
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MRF: conceptualisation, drafting of paper, review, approval of the final manuscript; JNA: conceptualisation, drafting of paper, review and approval of the final manuscript, LW: conceptualisation, drafting of paper, review and approval of the final manuscript, DPD: conceptualisation, drafting of paper, review and approval of the final manuscript. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Miguel R. Ferreira.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferreira, M.R., Andreyev, J.N., Wedlake, L. et al. Comment on “Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients”. Br J Cancer 128, 711–712 (2023). https://doi.org/10.1038/s41416-023-02163-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-023-02163-8

Search

Advanced search

Quick links